banner

Products

CAS 375823-41-9 Tocilizumab/Actemra/Actemra 200/Anti-Il-6r Tocilizumab/Atlizumab/R 1569/Roactemra/Tocilizumab, Atlizumab/Tocilizumab

CAS 375823-41-9 Tocilizumab/Actemra/Actemra 200/Anti-Il-6r Tocilizumab/Atlizumab/R 1569/Roactemra/Tocilizumab, Atlizumab/Tocilizumab

CAS 375823-41-9 Tocilizumab/Actemra/Actemra 200/Anti-Il-6r Tocilizumab/Atlizumab/R 1569/Roactemra/Tocilizumab, Atlizuma
SHARE

Description

Basic Info
Transport Package According to Customer Requests
Specification 98%
Trademark AFINE
Origin China
Production Capacity 300
Product Description

CAS 375823-41-9 Tocilizumab/Actemra/Actemra 200/Anti-Il-6r Tocilizumab/Atlizumab/R 1569/Roactemra/Tocilizumab, Atlizumab/Tocilizumab

TOCILIZUMAB CAS 375823-41-9
TOCILIZUMAB CAS NO. : 375823-41-9 MOLECULAR FORMULA: C14H12O3 MOLECULAR WEIGHT: 0 EINECS NO. : 248-451-4 APPEARANCE:OFF-WHITE TO TAN POWDERMOLECULAR WEIGHT:228.24328DENSITY:1.359BOILING POINT:449.1 OC AT 760 MMHGFLASH POINT:222.3 OCSTORAGE TEMPERATURE:?20°CSTABILITY:STABLE AT NORMAL TEMPERATURES AND PRESSURES.PURITY: ≥98%PACKAGING:ACCORDING TO CUSTOMER REQUESTSCOUNTRY OF ORIGIN:CHINA

CAS 375823-41-9 Tocilizumab/Actemra/Actemra 200/Anti-Il-6r Tocilizumab/Atlizumab/R 1569/Roactemra/Tocilizumab, Atlizumab/Tocilizumab

Our Services1. New Molecules R&D2. Own test center HPLC NMR GC LC-MS3. API and Intermediates from China reputed manufacturers4. Documents support COA MOA MSDS DMF open partOur advantages1. Government awarded company. Top 100 enterprises in Hangzhou2. Quality warrant. If any quality failure. we 100% return the payment or replacement3.More than 14 years experiences in pharmaceutical and chemical international trading4.Fast response on customers request and fast shipment

CAS 375823-41-9 Tocilizumab/Actemra/Actemra 200/Anti-Il-6r Tocilizumab/Atlizumab/R 1569/Roactemra/Tocilizumab, Atlizumab/Tocilizumab

CAS 375823-41-9 Tocilizumab/Actemra/Actemra 200/Anti-Il-6r Tocilizumab/Atlizumab/R 1569/Roactemra/Tocilizumab, Atlizumab/Tocilizumab

CAS 375823-41-9 Tocilizumab/Actemra/Actemra 200/Anti-Il-6r Tocilizumab/Atlizumab/R 1569/Roactemra/Tocilizumab, Atlizumab/Tocilizumab


Our Contact